Teradyne, Inc. (NASDAQ:TER) President and CEO Gregory Stephen Smith recently sold 3,080 shares of the company's common stock, according to an SEC filing. The transaction, which took place on December 16, 2024, was executed at a price of $130.00 per share, totaling $400,400. Following this sale, Smith retains ownership of approximately 77,656 shares in the company. The sale occurred near recent trading levels, with the stock currently at $123.77. InvestingPro data shows Teradyne has delivered strong returns this year, up 18.4% YTD, with analysts maintaining a moderate buy consensus and a price target range of $111-$180. The sale was conducted under a pre-established Rule 10b5-1 trading plan, which Smith adopted on June 7, 2024. With a market capitalization of $20.3 billion and an overall "GOOD" Financial Health rating from InvestingPro, Teradyne maintains a solid position in the semiconductor testing equipment market. For deeper insights and exclusive analysis, including Fair Value estimates and comprehensive financial metrics, investors can access the detailed Pro Research Report available on InvestingPro.
In other recent news, Teradyne, a provider of automated test equipment, has witnessed a series of upgrades and downgrades in its stock outlook from various analysts. JPMorgan (NYSE:JPM) raised Teradyne's stock outlook from Neutral to Overweight, citing potential growth due to market expansion across sectors. This is contrasted by Craig-Hallum's decision to cut its price target on Teradyne's shares, citing mixed performance across business segments. Evercore ISI also adjusted its price target for Teradyne, despite the company's September quarter earnings surpassing expectations.
Teradyne's revenue growth is expected to accelerate, with a low-20% increase in 2025 and a high-20% rise in 2026, according to JPMorgan. The company's total addressable market (TAM) is also projected to grow, reaching $7.6 billion in 2026. On the other hand, Craig-Hallum has a more cautious outlook, reducing its price target based on a 17x multiple applied to Teradyne's mid-term earnings per share (EPS) model.
Evercore ISI has revised its 2024 revenue growth outlook for Teradyne to 5% year-over-year, driven by strength in AI-driven High Bandwidth (NASDAQ:BAND) Memory (HBM) and networking testers. The firm also increased its 2024 System-on-Chip (SOC) Total (EPA:TTEF) Addressable Market (TAM) estimate for Teradyne to $4.2 billion.
These are recent developments for Teradyne, which beat third-quarter expectations with sales reaching $737 million and non-GAAP earnings per share at $0.90. The company also reported record revenue in the Memory Test business due to high demand for HBM DRAM.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.